Melo Daniela, Ferreira Fátima, Teles Maria José, Porto Graça, Coimbra Susana, Rocha Susana, Santos-Silva Alice
UCIBIO-Applied Molecular Biosciences Unit, Laboratory of Biochemistry, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4051-401 Porto, Portugal.
Associate Laboratory i4HB, Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4051-401 Porto, Portugal.
Antioxidants (Basel). 2024 May 22;13(6):629. doi: 10.3390/antiox13060629.
Catalase (CAT), glutathione peroxidase (GPx), and peroxiredoxin 2 (Prx2) can counteract the deleterious effects of oxidative stress (OS). Their binding to the red blood cell (RBC) membrane has been reported in non-immune hemolytic anemias (NIHAs). Our aim was to evaluate the relationships between CAT, GPx, and Prx2, focusing on their role at the RBC membrane, in hereditary spherocytosis (HS), sickle cell disease (SCD), β-thalassemia (β-thal), and healthy individuals. The studies were performed in plasma and in the RBC cytosol and membrane, evaluating OS biomarkers and the enzymatic activities and/or the amounts of CAT, GPx, and Prx2. The binding of the enzymes to the membrane appears to be the primary protective mechanism against oxidative membrane injuries in healthy RBCs. In HS (unsplenectomized) and β-thal, translocation from the cytosol to the membrane of CAT and Prx2, respectively, was observed, probably to counteract lipid peroxidation. RBCs from splenectomized HS patients showed the highest membrane-bound hemoglobin, CAT, and GPx amounts in the membrane. SCD patients presented the lowest amount of enzyme linkage, possibly due to structural changes induced by sickle hemoglobin. The OS-induced changes and antioxidant response were different between the studied NIHAs and may contribute to the different clinical patterns in these patients.
过氧化氢酶(CAT)、谷胱甘肽过氧化物酶(GPx)和过氧化物还原酶2(Prx2)可以对抗氧化应激(OS)的有害影响。在非免疫性溶血性贫血(NIHA)中,已有它们与红细胞(RBC)膜结合的报道。我们的目的是评估CAT、GPx和Prx2之间的关系,重点关注它们在遗传性球形红细胞增多症(HS)、镰状细胞病(SCD)、β地中海贫血(β-thal)以及健康个体的红细胞膜上的作用。研究在血浆、红细胞胞质溶胶和膜中进行,评估氧化应激生物标志物以及CAT、GPx和Prx2的酶活性和/或含量。在健康的红细胞中,这些酶与膜的结合似乎是对抗氧化膜损伤的主要保护机制。在HS(未行脾切除术)和β-thal中,分别观察到CAT和Prx2从胞质溶胶向膜的转位,这可能是为了对抗脂质过氧化。脾切除术后的HS患者的红细胞在膜上显示出最高的膜结合血红蛋白、CAT和GPx含量。SCD患者的酶结合量最低,这可能是由于镰状血红蛋白引起的结构变化所致。在研究的非免疫性溶血性贫血中,氧化应激诱导的变化和抗氧化反应有所不同,这可能导致这些患者出现不同的临床症状。